<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">OTO</journal-id>
<journal-id journal-id-type="hwp">spoto</journal-id>
<journal-title>Otolaryngology–Head and Neck Surgery</journal-title>
<issn pub-type="ppub">0194-5998</issn>
<issn pub-type="epub">1097-6817</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0194599812471500</article-id>
<article-id pub-id-type="publisher-id">10.1177_0194599812471500</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Invited Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Practical Guide to Understanding Multivariable Analyses, Part B</article-title>
<subtitle>Conjunctive Consolidation</subtitle>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Neely</surname><given-names>J. Gail</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-0194599812471500">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Lieu</surname><given-names>Judith E. Cho</given-names></name>
<degrees>MD, MSPH</degrees>
<xref ref-type="aff" rid="aff1-0194599812471500">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Sequeira</surname><given-names>Sunitha M.</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-0194599812471500">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Graboyes</surname><given-names>Evan</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-0194599812471500">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Paniello</surname><given-names>Randal C.</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-0194599812471500">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Nussenbaum</surname><given-names>Brian</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-0194599812471500">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Grindler</surname><given-names>David J.</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-0194599812471500">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Voelker</surname><given-names>Courtney C. J.</given-names></name>
<degrees>MD, DPhil</degrees>
<xref ref-type="aff" rid="aff1-0194599812471500">1</xref>
</contrib>
</contrib-group>
<aff id="aff1-0194599812471500">
<label>1</label>Practical Guides Writing Group, Department of Otolaryngology–Head and Neck Surgery, Washington University School of Medicine, St Louis, Missouri, USA</aff>
<author-notes>
<corresp id="corresp1-0194599812471500">J. (John) Gail Neely, MD, Professor and Director, Otology/Neurotology/Base of Skull Surgery, Department of Otolaryngology–Head and Neck Surgery, Washington University School of Medicine, 660 S. Euclid Ave, Box 8115, St Louis, MO 63110, USA Email: <email>jgneely@aol.com</email>; <email>neelyg@ent.wustl.edu</email>
</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>3</month>
<year>2013</year>
</pub-date>
<volume>148</volume>
<issue>3</issue>
<fpage>359</fpage>
<lpage>365</lpage>
<history>
<date date-type="received">
<day>15</day>
<month>11</month>
<year>2012</year>
</date>
<date date-type="accepted">
<day>27</day>
<month>11</month>
<year>2012</year>
</date>
</history>
<permissions>
<copyright-statement>© American Academy of Otolaryngology—Head and Neck Surgery Foundation 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="society">Official journal of the American Academy of Otolaryngology–Head and Neck Surgery Foundation</copyright-holder>
</permissions>
<abstract>
<p>Conjunctive consolidation, one method of multivariable analysis by arranging data into clusters, is intuitive and transparent. An unexpected consequence in writing this article was the discovery of just how useful it is in critically analyzing articles and in designing new projects. It has stimulated a fresh understanding as to the value of multivariable thinking in all clinical research. This article is organized into the sequential steps for performing conjunctive consolidation for critically analyzing an article of interest and for completing the process, pending all required data are available. Investigators, particularly those who perform clinical research, should consider conjunctive consolidation as a valuable method of multivariable analysis with which to report data.</p>
</abstract>
<kwd-group>
<kwd>conjunctive consolidation</kwd>
<kwd>multivariable analysis</kwd>
<kwd>statistics</kwd>
<kwd>research design</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>Writing about multivariable analysis has had some unexpected and amazing consequences. One needs only to share with a colleague something about multivariable analysis to see his or her eyes glaze over. The thought of multivariable analysis often elicits a negative visceral response, and one can become overwhelmed and disconnected from the very beginning.</p>
<p>Conversely, arranging data into clusters is transparent; one can see exactly what is happening. Conjunctive consolidation is a multivariable method that arranges data into clusters and allows an investigator to <italic>think</italic> about the relevance of all the variables. Amazingly, it stimulates the tendency to think in multivariable terms when critically reviewing articles and designing new projects. Clinical research is complex, with a myriad of variables that may influence a target outcome. It is prudent, therefore, that projects be designed and reported with multivariable effects in mind.</p>
<p>This article is organized into the sequential steps for performing conjunctive consolidation for critically analyzing an article of interest and for completing the process, pending all required data are available (<xref ref-type="table" rid="table1-0194599812471500"><bold>Table 1</bold></xref>).</p>
<table-wrap id="table1-0194599812471500" position="float">
<label>Table 1.</label>
<caption>
<p>Multivariable Thinking</p>
</caption>
<graphic alternate-form-of="table1-0194599812471500" xlink:href="10.1177_0194599812471500-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th align="left" colspan="5">(A) Basic Organization of Designing Data Collection</th>
</tr>
<tr>
<th align="left">Subject ID #</th>
<th align="center">Variable A: Category a1 or Category a2 or Category a3</th>
<th align="center">Variable B: Category b1 or Category b2</th>
<th align="center">Variable C: Dimensional (Record Continuous Variable)</th>
<th align="center">Variable D: Category d1 or Category d2 or Category d3 or Category d4</th>
</tr>
</thead>
<tbody>
<tr>
<td colspan="5">0001</td>
</tr>
<tr>
<td colspan="5">0002</td>
</tr>
<tr>
<td colspan="5">0004</td>
</tr>
<tr>
<th align="left" colspan="5">(B) Steps in Performing Conjunctive Consolidation</th>
</tr>
<tr>
<td valign="top">Step 1</td>
<td colspan="4">Assessment for data adequacy
<list id="list1-0194599812471500" list-type="alpha-lower">
<list-item><p>Are all of the important variables of interest considered?</p></list-item>
<list-item><p>Are there enough data available for these variables that the target outcomes associated with each category can be determined? In addition, are there enough data to support internal cells for conjoining variables?</p></list-item>
<list-item><p>Is the number of subjects in each variable category at or above the modicum of 20 subjects/subgroup?</p></list-item></list></td>
</tr>
<tr>
<td valign="top">Step 2</td>
<td colspan="4">Assessment of intercategorical gradients and bivariate analysis
<list id="list2-0194599812471500" list-type="alpha-lower">
<list-item><p>Are the intercategorical gradients greater than 10%?</p></list-item>
<list-item><p>b. Are the category outcomes statistically significant?</p></list-item></list></td>
</tr>
<tr>
<td valign="top">Step 3</td>
<td colspan="4">Examining candidate conjunctions and conjoining variables
<list id="list3-0194599812471500" list-type="alpha-lower">
<list-item><p>If the number of variables is k, then k(k − 1)/2 tables can be created.</p></list-item>
<list-item><p>Select the initial pairing for consolidation:
<list id="list4-0194599812471500" list-type="order">
<list-item><p> Is the pairing of variables biologically or clinically sensible?</p></list-item>
<list-item><p> Is there a double gradient?</p></list-item></list></p></list-item></list></td>
</tr>
<tr>
<td valign="top">Step 4</td>
<td colspan="4">Consolidation
<list id="list5-0194599812471500" list-type="alpha-lower">
<list-item><p>Cluster cells that have similar target outcomes and pathobiology or other scientific medical attributes.</p></list-item>
<list-item><p>New composite stages typically expand the gradients of the variables.</p></list-item></list></td>
</tr>
</tbody>
</table>
</table-wrap>
<sec id="section1-0194599812471500">
<title>Overview, Rationale, and Utility</title>
<p>As described in Part A, multivariable analyses are used to determine the degree and direction of effects that independent (predictor) variables have on the dependent (outcome) variable, in addition to the main independent variable under study (such as treatment).<sup><xref ref-type="bibr" rid="bibr1-0194599812471500">1</xref></sup> These techniques may be categorized as (1) mathematical models, as discussed in Part A, or (2) cluster arrangements.<sup><xref ref-type="bibr" rid="bibr2-0194599812471500">2</xref></sup> One commonly used technique of arranging data into clusters is conjunctive consolidation. Part A was designed to give the reader a general understanding of the complex mathematical models. Conversely, Part B will provide the reader with a basic understanding of conjunctive consolidation and demonstrate how to perform this task, via examples that illustrate the principles of this technique.</p>
<p>Conjunctive consolidation aims to combine variables that independently influence the outcome, stratifying the data within the combined variables to show the composite effect on the outcome. Conjunctive consolidation examines the effects of sequential pairs of variables, first by assessing the outcome gradients of potentially important variables, then conjoining these variables into compound clusters, and ultimately consolidating the results to form a new combined variable staging system.<sup><xref ref-type="bibr" rid="bibr2-0194599812471500">2</xref><xref ref-type="bibr" rid="bibr3-0194599812471500"/><xref ref-type="bibr" rid="bibr4-0194599812471500"/><xref ref-type="bibr" rid="bibr5-0194599812471500"/><xref ref-type="bibr" rid="bibr6-0194599812471500"/><xref ref-type="bibr" rid="bibr7-0194599812471500"/>-<xref ref-type="bibr" rid="bibr8-0194599812471500">8</xref></sup>
</p>
<p>The rationale and utility of grouping data into clusters and joining pairs of variables is the relative ease and transparency of the data review and analysis of the multivariable effects. Grouping data does not negate further algebraic analyses but does clarify what the data contain. Thus, conjunctive consolidation is an effective method to analyze one’s own research data. In addition, it is useful in studying published reports and pilot data, to understand available evidence and to focus quantitative questions for further research. It also immediately draws attention to the necessity to identify covariates that may modulate the effect of an intervention to properly design and/or critically analyze a trial. Because conjunctive consolidation intrinsically stratifies data, it is tremendously useful in the development of prognostic staging systems, such as for cancer survival. It allows many clinical factors to be incorporated into a staging system in a manner that makes clinical sense and adds complexity without increasing the number of groups or categories involved.</p>
<p><xref ref-type="table" rid="table2-0194599812471500"><bold>Table 2</bold></xref> and <xref ref-type="table" rid="table3-0194599812471500"><bold>Table 3</bold></xref> are a glossary of terms and an illustration of the position of those terms, respectively, which can help in understanding conjunctive consolidation and provide a quick review of a published article.</p>
<table-wrap id="table2-0194599812471500" position="float">
<label>Table 2.</label>
<caption>
<p>Glossary</p>
</caption>
<graphic alternate-form-of="table2-0194599812471500" xlink:href="10.1177_0194599812471500-table2.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th align="left">Item</th>
<th align="center">Description</th>
</tr>
</thead>
<tbody>
<tr>
<td>Variable</td>
<td>A characteristic or attribute of a person, thing, or event that varies within a defined range or domain. Examples: age, height, disease, test results</td>
</tr>
<tr>
<td>Category</td>
<td>The subunit of a variable within the defined range or domain in which characteristic may vary. Examples: age categories: minor, young adult, middle-aged adult, old adult; height categories: tall, medium, short; disease categories: diabetes mellitus (DM), no DM; test results categories: positive, negative</td>
</tr>
<tr>
<td>Cluster</td>
<td>A group of subjects within 1 category from 1 variable or a group of subjects within a category formed by consolidating several categories from several variables. Examples: simple (single) category cluster: young adults; compound (composite) category cluster: young adult, short, diabetic, test-positive subjects</td>
</tr>
<tr>
<td>m = number of ranked categories of a variable</td>
<td>Examples from “categories” above: age: m = 4; height: m = 3; disease: m = 2; test: m = 2</td>
</tr>
<tr>
<td>m − 1 = number of intercategorical gradients</td>
<td>Examples: age: m − 1 = 3; height: m − 1 = 2; disease: m − 1 = 1; test: m − 1 = 1</td>
</tr>
<tr>
<td>Double gradient</td>
<td>Each variable being conjoined has a significant target gradient, suggesting an important independent effect on outcome</td>
</tr>
<tr>
<td>Minimum intercategory gradient</td>
<td>Minimal acceptable percentage difference (gradient) <italic>between</italic> clusters achieving the target (outcome) variable of interest of 10% or greater. Examples of age-variable clusters having the target variable “healthy”: minors 100%, young adults 90%, middle aged 70%, old 30%<break/>Intercategory gradients: 10%, 20%, 40%</td>
</tr>
<tr>
<td>Minimum intrasystem gradient</td>
<td>Minimal total percentage gradient for the whole variable system is number of intercategorical gradients available times the minimum intercategory gradient. This is (m − 1) * 10%.<break/>Example: age intercategorical gradients available = 3 times 10% = 30% = minimal intrasystem gradient. Examples of age-variable clusters having the target variable “healthy”: minors 100%, young 90%, middle aged 70%, old 30%; total intrasystem gradient 100 − 30 = 70% (passes the minimum)</td>
</tr>
<tr>
<td>Strata</td>
<td>Single or composite categories relating to the target variable. Examples: single-variable categories for age forming 4 strata: minor, young adult, middle aged, old; composite variable categories for specific height and age forming 2 strata: short, middle aged</td>
</tr>
<tr>
<td>Modicum = minimum size of subgroup (stratum or cell)</td>
<td>Twenty subjects/stratum or cell are required for statistical stability. Examples: age having 4 strata: 20 * 4 = 80; composite variable age and height forming 2 strata: 20 * 2 = 40.</td>
</tr>
<tr>
<td>Events per variable (epv) ≥10 to 20</td>
<td>Similar to modicum in conjunctive consolidation, target events per each independent variable in algebraic multivariable analysis models require 20 events/variable for statistical stability; less than 10 events/variable is very unstable. Example: 4 variables require 80 events or at least 40 events.</td>
</tr>
<tr>
<td>Optimum number of strata in a staging system</td>
<td>5 or less, not 2</td>
</tr>
<tr>
<td>Number of tables</td>
<td>Tables formed by conjoining pairs of variables. Total available tables that can be formed from k variables. For k variables, number of tables = k(k − 1)/2; thus, for 4 variables, 4 * 3/2 = 12/2 = 6 tables</td>
</tr>
<tr>
<td>Conjunctive</td>
<td>Pairwise conjunction of variables (tables) to form a new composite variable</td>
</tr>
<tr>
<td>Consolidation</td>
<td>Process of consolidating 2 or more categories of the new composite variable into a staging system</td>
</tr>
<tr>
<td>Objective of conjunctive consolidation</td>
<td>Find and combine the most important variables that influence the target variable of interest (usually outcome)</td>
</tr>
<tr>
<td>Ordered neighbors</td>
<td>Adjacent cells (same row, or same column, or touching diagonally) in a cross-tabulation of 2 variables having similar biological characteristics (biological similarity) and similar target outcome rates (statistical isometry)</td>
</tr>
<tr>
<td>Statistical isometry</td>
<td>Neighboring cells having similar target (outcome) rates</td>
</tr>
<tr>
<td>Biological similarity (concordance)</td>
<td>Subjects in a stratum, or a composite category, having similar (concordant) pathobiology or other scientific medical attributes that justify conjunction</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="table3-0194599812471500" position="float">
<label>Table 3.</label>
<caption>
<p>Illustration of Glossary Terms Positions</p>
</caption>
<graphic alternate-form-of="table3-0194599812471500" xlink:href="10.1177_0194599812471500-table3.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th align="left">Variable A</th>
<th align="center">Clusters</th>
<th align="center" colspan="2">Gradients</th>
</tr>
</thead>
<tbody>
<tr>
<td>Category a1 stratum</td>
<td>Single category cluster a1t/n (%)</td>
<td/>
<td>Intrasystem gradient A3-A1</td>
</tr>
<tr>
<td/>
<td/>
<td>Intercategorical gradient A2-A1</td>
<td/>
</tr>
<tr>
<td>Category a2 stratum</td>
<td>Single category cluster a2t/n (%)</td>
<td/>
<td/>
</tr>
<tr>
<td/>
<td/>
<td>Intercategorical gradient A3-A2</td>
<td/>
</tr>
<tr>
<td>Category a3 stratum</td>
<td>Single category cluster a3t/n (%)</td>
<td/>
<td/>
</tr>
<tr>
<td>Number of ranked categoriesm = 3</td>
<td/>
<td>Number of intercategorical gradients m − 1 = 2</td>
<td/>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0194599812471500">
<p>t = number of subjects achieving target outcome; n = total number in cluster; t/n = proportion of subjects achieving target outcome; (%) = t/n as a percentage for determining gradients (% difference between clusters).</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section2-0194599812471500">
<title>Performing Conjunctive Consolidation</title>
<p>Conjunctive consolidation analyzes categorical variables (nominal, dichotomous, ordinal scales). Dimensional (continuous) variables must be segmented into a dichotomous or ordinal scale for analysis (eg, dividing age into young, middle, old). The target outcome (dependent) variable must be binary (eg, incomplete or complete recovery of facial function). The levels into which categorical variables may vary are known as <italic>categories</italic>.</p>
<p>The transparency of conjunctive consolidation compels multivariable thinking. This can be seen even when a full conjunctive consolidation cannot be done because of lack of enough data. To illustrate this, we looked at Peitersen’s beautiful supplement on 1701 untreated Bell’s palsy patients, often quoted as a “gold standard” of the natural history of Bell’s palsy.<sup><xref ref-type="bibr" rid="bibr9-0194599812471500">9</xref></sup> Peitersen analyzed many variables for their association with recovery of facial function; this setting is optimal for the use of conjunctive consolidation to develop a prognostic staging system for facial function recovery.</p>
<sec id="section3-0194599812471500">
<title>Step 1: Assessment of Data Adequacy</title>
<p>Three quick things to look at to determine the adequacy of the data are the following:</p>
<list id="list6-0194599812471500" list-type="order">
<list-item>
<p>Are most or all of the independent predictor variables of interest considered in the study? For example, Peitersen<sup><xref ref-type="bibr" rid="bibr9-0194599812471500">9</xref></sup> studied the variables of sex, age, taste dysfunction, Schirmer tear test results, degree of onset paralysis, postauricular pain, stapedial reflexes, and pregnancy, which are all variables of interest in studying recovery of facial function.</p>
</list-item>
<list-item>
<p>Are there enough data available for these variables that the outcomes associated with each category can be determined? In addition, are there enough data to support the internal cells for conjoining variables? In other words, all the individual patient data must be accessible, rather than just group summaries.</p>
</list-item>
</list>
<p>The application of conjunctive consolidation to analysis of the literature is often limited by the absence of raw data. This is illustrated with the data presented in Peitersen’s article.<sup><xref ref-type="bibr" rid="bibr9-0194599812471500">9</xref></sup> Embarking on this journey into understanding conjunctive consolidation, we were initially excited by the possibility of applying conjunctive consolidation to these data to construct a prognostic system for Bell’s palsy. There were abundant data for each variable category associated with outcomes. However, there was not sufficient transparency of the data to support internal cells for conjoining variables. Most instructive was realizing that one cannot perform conjunctive consolidation without actual raw data. Despite the impossibility of completing a full conjunction because of missing data, the utility of the transparency of this multivariable look unexpectedly revealed a potential completely new understanding of Bell’s palsy. Even though conjunctive consolidation could not be completed, attempting to configure the available data into that format resulted in a new discovery of just how important age may be on full recovery from Bell’s palsy. This exemplified another principle of discovery: failure to achieve a goal can sometimes be more instructive than when all goes as planned.</p>
<p>In addition, it should be remembered that the usual “<xref ref-type="table" rid="table1-0194599812471500">Table 1</xref>” in most clinical research, which compares the baseline variables in the groups, is designed to determine whether the groups are comparable. That table does not substitute for determining the effect of those variables on the outcome.</p>
<list id="list7-0194599812471500" list-type="simple">
<list-item>
<p>3. Are the number of subjects in each variable category at or above the modicum of 20 subjects/category, or does the total number of subjects suggest that there may be 20 or more subjects in each category? Looking at the variable with the most categories helps determine the general adequacy of numbers. For example, if there are 10 variables and 5 seem biologically sensible, and 1 variable has 4 categories and the others have 3 or 2 categories, the 4-category variable should have 4 × 20 or 80 subjects or more. Peitersen’s work<sup><xref ref-type="bibr" rid="bibr9-0194599812471500">9</xref></sup> had enough subjects, just not enough detailed information allowing conjunction.</p>
</list-item>
</list>
</sec>
<sec id="section4-0194599812471500">
<title>Step 2: Assessment of Intercategorical Gradients and Bivariate Analysis</title>
<p>Realizing it was not possible to continue conjunctive consolidation using Peitersen’s work,<sup><xref ref-type="bibr" rid="bibr9-0194599812471500">9</xref></sup> a hypothetical data set was constructed using “poor recovery of facial function in facial paralysis” as the target outcome (<xref ref-type="table" rid="table4-0194599812471500"><bold>Table 4</bold></xref>). Two variables were formulated, 1 with 3 categories (eg, “age”) and the other with 2 categories (eg, “severity of paralysis at onset”). The proportion of subjects in each stratum within a single categorical variable having the target outcome (Y) of “incomplete recovery” is listed in the middle column. The intercategorical gradient of each stratum exceeded the 10% minimum intercategorical gradient and the minimum intrasystem gradient (m − 1 * 10%), as well as the 20% required minimum for variable A and 10% for variable B.</p>
<table-wrap id="table4-0194599812471500" position="float">
<label>Table 4.</label>
<caption>
<p>Hypothetical Data Set for Conjunctive Consolidation</p>
</caption>
<graphic alternate-form-of="table4-0194599812471500" xlink:href="10.1177_0194599812471500-table4.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup>
<tbody>
<tr>
<td colspan="5">Binary target outcome variable Y = (yes/no)</td>
</tr>
<tr>
<td colspan="5">Two predictor variables passing bivariate analysis:</td>
</tr>
<tr>
<td colspan="5"> Variable A, age: 3 categories, with 16%, 29%, and 51% having outcome Y</td>
</tr>
<tr>
<td colspan="5"> Variable B, onset paralysis: 2 categories, with 21% and 43% having outcome Y</td>
</tr>
<tr>
<th align="left" colspan="5">Target Outcomes of Poor Recovery (Y) in Facial Paralysis</th>
</tr>
<tr>
<th align="left">Variable</th>
<th align="center">Category</th>
<th align="center">Proportion with Outcome Y, No. (%)</th>
<th align="center" colspan="2">Gradients</th>
</tr>
<tr>
<th/>
<th/>
<th/>
<th align="center">Intercategorical</th>
<th align="center">Intrasystem</th>
</tr>
<tr>
<td>A</td>
<td>a1 Stratum</td>
<td>23/140 (16)</td>
<td/>
<td>35%</td>
</tr>
<tr>
<td>Age</td>
<td>0-30 y</td>
<td/>
<td/>
<td/>
</tr>
<tr>
<td><italic>P</italic> &lt; .001</td>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td/>
<td>a2 Stratum</td>
<td>73/250 (29)</td>
<td>a2-a1 = 13%</td>
<td/>
</tr>
<tr>
<td/>
<td>31-60 y</td>
<td/>
<td/>
<td/>
</tr>
<tr>
<td/>
<td>a3 Stratum</td>
<td>81/160 (51)</td>
<td>a3-a2 = 22%</td>
<td/>
</tr>
<tr>
<td/>
<td>&gt;60 y</td>
<td/>
<td/>
<td/>
</tr>
<tr>
<td>B</td>
<td>b1 Stratum</td>
<td>57/270 (21)</td>
<td>b2-b1 = 22%</td>
<td>22%</td>
</tr>
<tr>
<td>Onset paralysis</td>
<td>Incomplete paralysis</td>
<td/>
<td/>
<td/>
</tr>
<tr>
<td><italic>P</italic> &lt; .001</td>
<td>b2 Stratum</td>
<td>120/280 (43)</td>
<td/>
<td/>
</tr>
<tr>
<td/>
<td>Complete paralysis</td>
<td/>
<td/>
<td/>
</tr>
</tbody>
</table>
</table-wrap>
<p>Bivariate analysis was performed to see if the outcome rates between categories within each variable were statistically different. To do this, a contingency table was constructed with 2 columns and enough rows for each variable, with the number of subjects with outcome Y in one column and the number without the outcome Y in the other. The rows were the categories in each variable. Bivariate analysis for proportions using χ<sup>2</sup> was calculated; the <italic>P</italic> value is shown for each variable.</p>
<p>Importantly, when these data were constructed, each variable was hypothetically deemed to have scientific medical attributes that were sensibly related to the target outcome and would justify conjunctive consolidation.</p>
</sec>
<sec id="section5-0194599812471500">
<title>Step 3: Examining Candidate Conjunctions and Conjoining Variables</title>
<p>In this step, each independent variable is paired with another, and combined outcomes are calculated in a table format. For the number k variables, k(k − 1)/2 tables are generated. The choice of the first table to analyze can be complex and relies on the pair of variables that makes the most biologic sense and the table with the largest double gradient. To highlight biologic sensibility, let’s return to our example of Bell’s palsy. A table conjoining degree of paralysis at onset and age may have more clinical applicability than a table conjoining degree of paralysis at onset and Schirmer test results, if one recognizes that an emergency department or primary care physician initially evaluates most facial paralyses and may have limited accessibility to Schirmer testing.</p>
<p>In the hypothetical data set, we chose to begin consolidation with conjoining variables A (age) and B (severity of paralysis at onset) due to their biologic sensibility (<xref ref-type="table" rid="table5-0194599812471500"><bold>Table 5A</bold></xref>). When configuring the combination of variables, gradients must go from best on the left to worst on the right and from best on the top to worst on the bottom. <italic>Best</italic> is relative to the target outcome. For example, if poor recovery is the target being analyzed, then the lowest rate is best; conversely, if good recovery is the target, the highest survival rate is the best. This configuration allows the subsequent consolidation of categories into new stages to be like “peeling the onion”—in other words, joining groups of categories from best to worst in aggregates while peeling away separate cells (J. F. Piccirillo, personal communication, 2012).</p>
<table-wrap id="table5-0194599812471500" position="float">
<label>Table 5.</label>
<caption>
<p>Hypothetical Data Set for Conjunctive Consolidation</p>
</caption>
<graphic alternate-form-of="table5-0194599812471500" xlink:href="10.1177_0194599812471500-table5.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left" colspan="5">(A) Conjunction (Outcome Target Poor Recovery of Facial Function)</th>
</tr>
<tr>
<th/>
<th align="center">Variable A: Age<hr/></th>
<th align="center" colspan="3">Variable B: Onset Paralysis</th>
</tr>
<tr>
<th/>
<th/>
<th align="center">Category b1 Incomplete @ Onset<hr/></th>
<th align="center">Category b2 Complete @ Onset<hr/></th>
<th align="center">A Gradient 16% to 51%<hr/></th>
</tr>
<tr>
<th align="left">BEST</th>
<th/>
<th/>
<th/>
<th align="center">WORST</th>
</tr>
</thead>
<tbody>
<tr>
<td><bold>BEST</bold></td>
<td>Category <bold>0-30 y</bold></td>
<td>3/60 (5%) <bold>BEST</bold></td>
<td>20/80 (25%)</td>
<td>23/140 (16%)</td>
</tr>
<tr>
<td/>
<td>Category <bold>31-60 y</bold></td>
<td>33/150 (22%)</td>
<td>40/100 (40%)</td>
<td>73/250 (29%)</td>
</tr>
<tr>
<td><bold>WORST</bold></td>
<td>Category <bold>&gt;60 y</bold></td>
<td>21/60 (35%)</td>
<td>60/100 (60%) <bold>WORST</bold></td>
<td>81/160 (51%)</td>
</tr>
<tr>
<td/>
<td><bold>B Gradient 21% to 43%</bold></td>
<td>57/270 (21%)</td>
<td>120/280 (43%)</td>
<td><bold>177/550 (32%)</bold></td>
</tr>
<tr>
<th align="left" colspan="5">(B) Consolidation (Outcome Target Poor Recovery of Facial Function)</th>
</tr>
<tr>
<th align="left">Age</th>
<th align="center" colspan="2">Onset Paralysis<hr/></th>
<th/>
<th/>
</tr>
<tr>
<th/>
<th align="center">Incomplete @ Onset</th>
<th align="center">Complete @ Onset</th>
<th align="center" colspan="2">Age Gradient 16% to 51%</th>
</tr>
<tr>
<td><bold>0-30 y</bold></td>
<td>3/60 (5%)</td>
<td>20/80 (25%)</td>
<td colspan="2">(3 + 20)/(60 + 80)</td>
</tr>
<tr>
<td/>
<td>Stage I</td>
<td>Stage II</td>
<td colspan="2">23/140 <bold>(16%)</bold></td>
</tr>
<tr>
<td><bold>31-60 y</bold></td>
<td>33/150 (22%)</td>
<td>40/100 (40%)</td>
<td colspan="2">(33 + 40)/(150 + 100)</td>
</tr>
<tr>
<td/>
<td>Stage II</td>
<td>Stage III</td>
<td colspan="2">73/250 <bold>(29%)</bold></td>
</tr>
<tr>
<td><bold>&gt;60 y</bold></td>
<td>21/60 (35%)</td>
<td><bold>60/100 (60%)</bold></td>
<td colspan="2">(21 + 60)/(60 + 100)</td>
</tr>
<tr>
<td/>
<td>Stage III</td>
<td><bold>Stage IV</bold></td>
<td colspan="2">81/160 <bold>(51%)</bold></td>
</tr>
<tr>
<td><bold>Onset gradient</bold></td>
<td>(3 + 33 + 21)/(60 + 150 + 60)</td>
<td>(20 + 40 + 60)/(80 + 100 + 100)</td>
<td colspan="2"><bold>A = (23 + 73 + 81)/(140 + 250 + 160)</bold></td>
</tr>
<tr>
<td><bold>21% to 43%</bold></td>
<td>57/270 <bold>(21%)</bold></td>
<td>120/280 <bold>(43%)</bold></td>
<td colspan="2">
<bold>B = (57 + 120)/(270 + 280)</bold></td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td colspan="2">
<bold>Both = 177/550 (32%)</bold></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn2-0194599812471500">
<p>Result: New predictor variable, age-onset, with 4 levels: 5% 23%, 38%, and 60%. Consolidated internal cells are compound (composite) category clusters.</p>
<p><inline-graphic xlink:href="10.1177_0194599812471500-img1.tif"/></p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>Importantly, the table shows a crucial double gradient. <italic>Double gradient</italic> refers to the fact that each variable has a significant target gradient (equal to or greater than the minimal intercategorical gradient of 10%), suggesting an important independent effect on outcome. Also note that the sum of the numbers achieving the target outcome variable divided by the total numbers of the conjoining variables are the same; this is seen in the far bottom right marginal cell. This confirms that all the subjects are included in both variables.</p>
</sec>
<sec id="section6-0194599812471500">
<title>Step 4: Consolidating Variables</title>
<p><xref ref-type="table" rid="table5-0194599812471500"><bold>Table 5B</bold></xref> demonstrates the consolidation of the conjoined variables. Neighboring cells can be clustered according to categories with similar biologic characteristics and similar target outcomes. Consolidation of cells is performed using the concept of <italic>ordered neighbors</italic> in which adjacent 2 or more cells in the same row or columns or touching diagonally are joined into the same stage.</p>
<p>The purpose of conjunctive consolidation is to devise a clinically meaningful staging system when there is more than 1 variable that is important in predicting the outcome. This process generates a staging system gradient greater than either variable alone. In this example, the variable A “age” gradient ranged from 16% to 51% (difference 35%), and the variable B “severity of paralysis at onset” gradient ranged from 21% to 43% (difference 22%); the new age-onset variable staging system ranged from 5% to 60% (difference 55%).</p>
<p>It is possible to conjoin and consolidate other variables with the initial staging system. However, consolidating more than 3 variables is rarely fruitful and can be confusing. <xref ref-type="table" rid="table6-0194599812471500"><bold>Table 6</bold></xref> illustrates the addition of a third hypothetical variable, “comorbidities.” This variable was considered clinically important, had appropriate gradients, and showed a statistically significant difference between categories. This new staging system (age-onset-comorbidity) generated a gradient from 8% to 75% (difference 67%).</p>
<table-wrap id="table6-0194599812471500" position="float">
<label>Table 6.</label>
<caption>
<p>Conjunctive Consolidation: Addition of a Third Hypothetical Variable: Comorbidities</p>
</caption>
<graphic alternate-form-of="table6-0194599812471500" xlink:href="10.1177_0194599812471500-table6.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="center" colspan="4">Comorbidities, <italic>P</italic> &lt; .001</th>
</tr>
<tr>
<th align="left">Age-Onset</th>
<th align="center">Category “Few”</th>
<th align="center">Category “Many”</th>
<th/>
</tr>
</thead>
<tbody>
<tr>
<td>Stage I</td>
<td>1/25 (4%)</td>
<td>2/35 (6%)</td>
<td>3/60 <bold>(5%)</bold></td>
</tr>
<tr>
<td/>
<td><bold>alpha</bold></td>
<td><bold>alpha</bold></td>
<td/>
</tr>
<tr>
<td>Stage II</td>
<td>10/100 (10%)</td>
<td>43/130 (33%)</td>
<td>53/230 <bold>(23%)</bold></td>
</tr>
<tr>
<td/>
<td>
<bold>alpha</bold></td>
<td>
<bold>beta</bold></td>
<td/>
</tr>
<tr>
<td>Stage III</td>
<td>20/80 (25%)</td>
<td><bold>41/80 (51%)</bold></td>
<td>61/160 <bold>(38%)</bold></td>
</tr>
<tr>
<td/>
<td><bold>beta</bold></td>
<td>
<bold>gamma</bold></td>
<td/>
</tr>
<tr>
<td>Stage IV</td>
<td><bold>30/60 (50%)</bold></td>
<td>30/40 (75%)</td>
<td>60/100 <bold>(60%)</bold></td>
</tr>
<tr>
<td/>
<td><bold>gamma</bold></td>
<td>
<bold>delta</bold></td>
<td/>
</tr>
<tr>
<td/>
<td>61/265 (23%)</td>
<td>116/285 (41%)</td>
<td>177/550 <bold>(32%)</bold></td>
</tr>
</tbody>
</table>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left" colspan="2">New Staging System Gradient 8% to 75%<hr/></th>
</tr>
<tr>
<th align="left">Age-Onset-Comorbidities</th>
<th align="center">Poor Recovery of Facial Function</th>
</tr>
</thead>
<tbody>
<tr>
<td>Alpha</td>
<td>(1 + 10 + 2)/(25 + 100 + 35) <bold>(8%)</bold></td>
</tr>
<tr>
<td>Beta</td>
<td>(20 + 43)/(80 + 130) <bold>(30%)</bold></td>
</tr>
<tr>
<td>Gamma</td>
<td>(30 + 41)/(60 + 80) <bold>(51%)</bold></td>
</tr>
<tr>
<td>Delta</td>
<td>30/40 <bold>(75%)</bold></td>
</tr>
</tbody>
</table>
</table-wrap>
<p>Initially, we debated using only generic terms, such as variables A, B, and C, but instead chose to use potentially clinically meaningful terms for the hypothetically constructed data. This seemed to enhance and simplify further thought on the value of conjunctive consolidation. <xref ref-type="table" rid="table7-0194599812471500"><bold>Table 7</bold></xref> demonstrates how an evidence-based, data-driven (albeit hypothetical data) process such as conjunctive consolidation can lead to a prognostic stratification relative to an outcome. Once a substantive staging system has been developed using multivariable techniques to account for the conjoined effects of predictor variables, further refinements can be made to the system by validating against new data and determining treatment effects within the multivariable environment.</p>
<table-wrap id="table7-0194599812471500" position="float">
<label>Table 7.</label>
<caption>
<p>Hypothetical New Prognostic Stratification Organized Like TMN Staging</p>
</caption>
<graphic alternate-form-of="table7-0194599812471500" xlink:href="10.1177_0194599812471500-table7.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<tbody>
<tr>
<td colspan="4">Alpha: age 0-30, incomplete @ onset, few or many comorbidities 8%</td>
</tr>
<tr>
<td colspan="4"> Or age 0-30, complete @ onset, few comorbidities</td>
</tr>
<tr>
<td colspan="4"> Or age 31-60, incomplete @ onset, few comorbidities</td>
</tr>
<tr>
<td colspan="4">Beta: age &gt;60, incomplete @ onset, few comorbidities 30%</td>
</tr>
<tr>
<td colspan="4"> Or age 31-60, complete @ onset, few comorbidities</td>
</tr>
<tr>
<td colspan="4"> Or age 0-30, complete @ onset, many comorbidities</td>
</tr>
<tr>
<td colspan="4"> Or age 31-60, incomplete @ onset, many comorbidities</td>
</tr>
<tr>
<td colspan="4">Gamma: age &gt;60, complete @ onset, few comorbidities 51%</td>
</tr>
<tr>
<td colspan="4"> Or age &gt;60, incomplete @ onset, many comorbidities</td>
</tr>
<tr>
<td colspan="4"> Or age 31-60, complete @ onset, many comorbidities</td>
</tr>
<tr>
<td colspan="4">Delta: age &gt;60, complete @ onset, many comorbidities 75%</td>
</tr>
<tr>
<th align="left">Stage (% Poor Outcome)</th>
<th align="center">Age</th>
<th align="center">Paralysis @ Onset</th>
<th align="center">Comorbidities</th>
</tr>
<tr>
<td rowspan="3" valign="top">Alpha (8%)</td>
<td>A1</td>
<td>P0</td>
<td>C any</td>
</tr>
<tr>
<td>A2</td>
<td>P1</td>
<td>C0</td>
</tr>
<tr>
<td>A3</td>
<td>P0</td>
<td>C0</td>
</tr>
<tr>
<td rowspan="4" valign="top">Beta (30%)</td>
<td>A3</td>
<td>P0</td>
<td>C0</td>
</tr>
<tr>
<td>A2</td>
<td>P1</td>
<td>C0</td>
</tr>
<tr>
<td>A1</td>
<td>P1</td>
<td>C1</td>
</tr>
<tr>
<td>A2</td>
<td>P0</td>
<td>C1</td>
</tr>
<tr>
<td rowspan="3" valign="top">Gamma (51%)</td>
<td>A3</td>
<td>P1</td>
<td>C0</td>
</tr>
<tr>
<td>A3</td>
<td>P0</td>
<td>C1</td>
</tr>
<tr>
<td>A2</td>
<td>P1</td>
<td>C1</td>
</tr>
<tr>
<td>Delta (75%)</td>
<td>A3</td>
<td>P1</td>
<td>C1</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn3-0194599812471500">
<p>Age: A1 = 0-30; A2 = 31-60; A3 = &gt;60. Paralysis at onset: P0 = incomplete; P1 = complete. Comorbidities: C0 = few; C1 = many.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>It should be noted that conjunctive consolidation need not work in every case. If the data do not adhere to the rules or if sufficient data are unavailable, the technique cannot be used. However, looking at data from a multivariable perspective can lead to new insights.</p>
</sec>
</sec>
<sec id="section7-0194599812471500" sec-type="conclusions">
<title>Conclusion</title>
<p>Conjunctive consolidation, one method of multivariable analysis by arranging data into clusters, is intuitive and transparent. An unexpected consequence in writing this article was the discovery of just how useful it is in critically analyzing articles and in designing new projects. It has stimulated a fresh understanding as to the value of multivariable thinking in all clinical research. Investigators, particularly those who perform clinical research, should consider conjunctive consolidation as a valuable method of multivariable analysis with which to report data.</p>
</sec>
<sec id="section8-0194599812471500">
<title>Author Contributions</title>
<p><bold>J. Gail Neely</bold>, substantial contributions to conception and design, acquisition of data, analysis and interpretation of data, drafting the article and revising it critically for important intellectual content, and final approval of the version to be published; <bold>Judith E. Cho Lieu</bold>, substantial contributions to conception and design, acquisition of data, analysis and interpretation of data, drafting the article and revising it critically for important intellectual content, and final approval of the version to be published; <bold>Sunitha M. Sequeira</bold>, substantial contributions to conception and design, acquisition of data, analysis and interpretation of data, drafting the article and revising it critically for important intellectual content, and final approval of the version to be published; <bold>Evan Graboyes</bold>, substantial contributions to conception and design, acquisition of data, analysis and interpretation of data, drafting the article and revising it critically for important intellectual content, and final approval of the version to be published; <bold>Randal C. Paniello</bold>, substantial contributions to conception and design, acquisition of data, analysis and interpretation of data, drafting the article and revising it critically for important intellectual content, and final approval of the version to be published; <bold>Brian Nussenbaum</bold>, substantial contributions to conception and design, acquisition of data, analysis and interpretation of data, drafting the article and revising it critically for important intellectual content, and final approval of the version to be published; <bold>David J. Grindler</bold>, substantial contributions to conception and design, acquisition of data, analysis and interpretation of data, drafting the article and revising it critically for important intellectual content, and final approval of the version to be published; <bold>Courtney C. J. Voelker</bold>, substantial contributions to conception and design, acquisition of data, analysis and interpretation of data, drafting the article and revising it critically for important intellectual content, and final approval of the version to be published.</p>
</sec>
<sec id="section9-0194599812471500">
<title>Disclosures</title>
<p><bold>Competing interests:</bold> None.</p>
<p><bold>Sponsorships:</bold> None.</p>
<p><bold>Funding source:</bold> None.</p>
</sec>
</body>
<back>
<ack>
<p>Our thanks for critical review of the manuscript go to Jay F. Piccirillo, MD, Vice-Chairman for Research, Director of Clinical Outcomes Research Office, Department of Otolaryngology–Head and Neck Surgery, Washington University School of Medicine, St Louis, Missouri.</p>
</ack>
<fn-group>
<fn fn-type="presented-at">
<p>No sponsorships or competing interests have been disclosed for this article.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0194599812471500">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Neely</surname><given-names>J</given-names></name>
<name><surname>Paniello</surname><given-names>R</given-names></name>
<name><surname>Lieu</surname><given-names>J</given-names></name>
<etal/>
</person-group>. <article-title>Practical guide to understanding multivariable analyses: part A</article-title> [published online October 3, 2012]. <source>Otolaryngol Head Neck Surg</source>. doi:<pub-id pub-id-type="doi">10.1177/0194599812462685</pub-id>.</citation>
</ref>
<ref id="bibr2-0194599812471500">
<label>2.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Feinstein</surname><given-names>AR</given-names></name>
</person-group>. <source>Multivariable Analysis: An Introduction</source>. <publisher-loc>New Haven, CT</publisher-loc>: <publisher-name>Yale University Press</publisher-name>; <year>1996</year>:<fpage>2</fpage>-<lpage>3</lpage>, <fpage>68</fpage>-<lpage>70</lpage>, <fpage>74</fpage>-<lpage>77</lpage>, <fpage>264</fpage>-<lpage>294</lpage>, <fpage>297</fpage>-<lpage>369</lpage>, <fpage>370</fpage>-<lpage>430</lpage>, <fpage>431</fpage>-<lpage>474</lpage>, <fpage>512</fpage>-<lpage>524</lpage>.</citation>
</ref>
<ref id="bibr3-0194599812471500">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Feinstein</surname><given-names>AR</given-names></name>
</person-group>. <article-title>Clinical biostatistics, XIV: the purposes of prognostic stratification</article-title>. <source>Clin Pharmacol Ther</source>. <year>1972</year>;<volume>13</volume>:<fpage>285</fpage>-<lpage>297</lpage>.</citation>
</ref>
<ref id="bibr4-0194599812471500">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Feinstein</surname><given-names>AR</given-names></name>
</person-group>. <article-title>Clinical biostatistics, XV: the process of prognostic stratification (part I)</article-title>. <source>Clin Pharmacol Ther</source>. <year>1972</year>;<volume>13</volume>:<fpage>442</fpage>-<lpage>457</lpage>.</citation>
</ref>
<ref id="bibr5-0194599812471500">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Feinstein</surname><given-names>AR</given-names></name>
<name><surname>Schimpff</surname><given-names>CR</given-names></name>
<name><surname>Hull</surname><given-names>EW</given-names></name>
</person-group>. <article-title>A reappraisal of staging and therapy for patients with cancer of the rectum, I: development of two new systems of staging</article-title>. <source>Arch Intern Med</source>. <year>1975</year>;<volume>135</volume>:<fpage>1441</fpage>-<lpage>1453</lpage>.</citation>
</ref>
<ref id="bibr6-0194599812471500">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Feinstein</surname><given-names>AR</given-names></name>
<name><surname>Wells</surname><given-names>CK</given-names></name>
</person-group>. <article-title>A clinical-severity staging system for patients with lung cancer</article-title>. <source>Medicine</source>. <year>1990</year>;<volume>69</volume>:<fpage>1</fpage>-<lpage>33</lpage>.</citation>
</ref>
<ref id="bibr7-0194599812471500">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lieu</surname><given-names>JEC</given-names></name>
</person-group>. <article-title>Development of staging and stratification systems</article-title>. <source>ORL</source>. <year>2004</year>;<volume>66</volume>:<fpage>173</fpage>-<lpage>179</lpage>.</citation>
</ref>
<ref id="bibr8-0194599812471500">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Patel</surname><given-names>U</given-names></name>
<name><surname>Spitznagel</surname><given-names>E</given-names></name>
<name><surname>Piccirillo</surname><given-names>J</given-names></name>
</person-group>. <article-title>Multivariate analyses to assess treatment effectiveness in advanced head and neck cancer</article-title>. <source>Arch Otolaryngol Head Neck Surg</source>. <year>2002</year>;<volume>128</volume>:<fpage>497</fpage>-<lpage>503</lpage>.</citation>
</ref>
<ref id="bibr9-0194599812471500">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Peitersen</surname><given-names>E</given-names></name>
</person-group>. <article-title>Bell’s palsy: the spontaneous course of 2,500 peripheral facial nerve palsies of different etiologies</article-title>. <source>Acta Otolaryngol Suppl</source>. <year>2002</year>;(<issue>549</issue>):<fpage>4</fpage>-<lpage>30</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>